Atrion Corp (ATRI) - Forward Price-to-Revenue Multiple

atrioncorp.com (ATRI) - corporate logo

The forward P/S based on forecasts demonstrates stable demand for Atrion Corporation (ATRI) cardiology and infusion products, where the value of 4.40 characterizes this level. Atrion Corporation (ATRI) is creating an ecosystem of high-precision components integrated into the OEM projects of B2B partners. Business resilience is supported by the control of polymer supplies and clinic demand for anesthesiology tubes while maintaining a healthy operating margin.

ATRI atrioncorp.com: Forward Price-to-Revenue Multiple in the range 07/04/2022 - 08/31/2024

Atrion - analytical breakdowns and key metrics (ATRI)

- market price and analyst price targets:
Price Chart Atrion Corp|ATRI - Fair Value Consensus
- market capitalization indicators:
Market Valuation Atrion|ATRI - Enterprise Value
- business book valuation details:
Net Assets per Single Share Atrion|ATRI - Company Net Assets|Market Capitalization to Book Value Ratio atrioncorp.com|ATRI - Company Assets
- issuer credit burden and liquidity indicators:
Debt to Equity Atrion Corporation|ATRI - Long-Term Debt to Capital Ratio|Short-Term Debt to Equity Ratio Atrion Corporation|ATRI - Company Cumulative Indebtedness|Debt to Book Capitalization Ratio Atrion Corp|ATRI - Long-Term Debt Volume|Company Short-Term Debts Atrion|Quick Liquidity Indicator atrioncorp.com
- business earnings and investment ratios data:
ATRI - Profit After Payment of Taxes|Expected Profit Atrion Corporation|ATRI - Company Value to Net Income|Forward P/E Multiple atrioncorp.com|ATRI - Growth-Adjusted Market Cap to Net Income|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Atrion Corporation Inc.|ATRI - Profit before interest, taxes and amortization|Earnings per share for the last twelve months Atrion|ATRI - Earnings per share for the last 12 months|Year-over-year net earnings per share growth for the last 12 months atrioncorp.com|ATRI - Earnings per share increase in current year|Earnings growth forecast for next year Atrion Corporation
- sales and revenue data:
ATRI - Company Sales|Company Projected Revenue atrioncorp.com|ATRI - Price to Sales|Price-to-Projected Revenue Ratio Atrion Corp.|ATRI - Revenue Dynamics YoY (Last Twelve Months)
General company analysis:ATRI (Atrion Corporation Inc.)
Original product of atrioncorp.com

For Atrion Corporation (ATRI), whose long-term contracts in the medical systems niche guarantee a stable cash flow, the forward P/S based on forecasts reflects the market value of one dollar of expected revenue. This chart demonstrates a balance between the premium for high customer stickiness and the risks of overpaying for future growth, confirming the fundamental resilience of the business during periods of macroeconomic factor revaluation.

Analysis of competing companies

Price-to-Projected Revenue Ratio Intuitive Surgical Inc ISRG|Forward P/S Multiple Danaher Corporation Inc. DHR|BDX - Price-to-Projected Revenue Ratio|STERIS plc (STE) - Forward Price-to-Revenue Multiple|WST: Forward P/S Multiple|Market Cap to Future Revenue Ratio Baxter International Inc. (BAX)|MASI (masimo.com) - Forward P/S Multiple|Market Cap to Future Revenue Ratio Stevanato Group Corp STVN|Forward Price-to-Revenue Multiple TFX (Teleflex Inc)|Merit Medical - Market Cap to Projected Revenue|Envista Holdings - Forward Price-to-Revenue Multiple|Price to Expected Revenue Ratio ICUI (ICU Medical Inc)|XRAY - Price-to-Projected Revenue Ratio|Market Cap to Expected Sales Ratio LeMaitre Corp LMAT|ATRC: Forward P/S Multiple|STAA - Market Cap to Expected Sales Ratio|NAGE (Chromadex Corp) - Forward P/S Multiple|ZimVie Inc (ZIMV) - Market Cap to Expected Sales Ratio|Forward P/S Multiple ANGO|CERS (Cerus Corporation) - Forward Price to Sales|Forward P/S Multiple TKNO (Alpha Teknova, Inc.)|Monogram Technologies (MGRM) - Market Cap to Future Revenue Ratio|STSS - Price-to-Projected Revenue Ratio|Market Cap to Expected Sales Ratio InfuSystem INFU|Utah Med (UTMD) - Price-to-Projected Revenue Ratio|Forward Price-to-Revenue Multiple KORU Medical Systems, Inc.|Forward Price-to-Revenue Multiple NYXH|Market Cap to Future Revenue Ratio Microbot Medical MBOT|Forward Price-to-Revenue Multiple PDEX (Pro-Dex)|Price-to-Projected Revenue Ratio ZTEK (Zentek Limited)|Price-to-Projected Revenue Ratio Elutia Inc. ELUT|Milestone Scientific (MLSS) - Market Cap to Future Revenue Ratio|nexgel.com - Forward P/S Multiple|Market Cap to Future Revenue Ratio Retractable Technologies Inc.|Harvard Bioscience Inc. (HBIO) - Price-to-Projected Revenue Ratio|Forward Price-to-Revenue Multiple Femasys Corp|Forward Price-to-Revenue Multiple MHUA|Market Cap to Future Revenue Ratio predictive-oncology.com POAI|Price-to-Projected Revenue Ratio Callan JMB Corp (CJMB)|Market Cap to Expected Sales Ratio neurometrix.com